Efficacy of pentoxifylline in prevention of contrast-induced nephropathy in angioplasty patients

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Urology and Nephrology

• Publication date

  2012-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11255-011-0053-4PMID 21898040
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.

  2009cited by this paper
• Sodium Bicarbonate vs Sodium Chloride for the Prevention of Contrast Medium–Induced Nephropathy in Patients Undergoing Coronary Angiography: A Randomized Trial

  2009cited by this paper
• N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial

  2009cited by this paper
• Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials

  2009cited by this paper
• Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study.

  2009cited by this paper
• Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial.

  2008cited by this paper
• Protective effect of pentoxifylline on contrast induced nephropathy.

  2008influential reference
• Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction.

  2007cited by this paper
• Prophylaxis of Contrast Material-Induced Nephropathy in Patients in Intensive Care : Acetylcysteine , Theophylline , or Both ? A Randomized Study

  2006cited by this paper
• Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN).

  2006cited by this paper
• Prophylaxis of contrast material-induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study.

  2006cited by this paper
• N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial

  2005cited by this paper
• Theophylline for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

  2005cited by this paper
• Ascorbic Acid Prevents Contrast-Mediated Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention

  2004cited by this paper
• N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity.

  2004cited by this paper
• Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.

  2004cited by this paper
• A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.

  2004cited by this paper
• Fenoldopam and N‐acetylcysteine for the Prevention of Radiographic Contrast Material—Induced Nephropathy: A Review

  2003cited by this paper
• The role of theophylline in contrast-induced nephropathy: a case-control study.

  2002cited by this paper
• Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency.

  1999cited by this paper
• Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock

  1996cited by this paper

• The role of pentoxifylline in preventing contrast-induced nephropathy in coronary angiography/intervention - systematic review, meta-analysis, and meta-regression of randomized controlled trials.

  2022cites this paper
• Small molecules as a source for acute kidney injury therapy.

  2022cites this paper
• Pentoxifylline for the prevention of contrast-induced nephropathy: systematic review and meta-analysis of randomised controlled trials

  2021cites this paper
• A randomized double-blinded placebo-controlled clinical trial on protective effects of pentoxifylline on gentamicin nephrotoxicity in infectious patients

  2021cites this paper
• Impact of Supplementation with Omega-3 in the Prevention of Contrast-Induced Nephropathy Following Elective Percutaneous Coronary Intervention in Patients with Chronic Kidney Disease: A Randomized Placebo-Controlled Trial

  2020influential citation
• Dysregulation of HULC promotes contrast-induced nephropathy (CIN) via regulating signaling pathway of miRNA-512 and prostaglandin E1 (PGE1)

  2020cites this paper
• Pentoxifylline for the prevention of contrast-induced nephropathy in diabetic patients undergoing angioplasty: a randomized controlled trial

  2019cites this paper
• A Randomized Double Blind Placebo Controlled Trial Examining the Effects of Pentoxifylline on Contrast Induced Nephropathy Reduction after Percutaneous Coronary Intervention in High Risk Candidates

  2019cites this paper
• Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis

  2018cites this paper
• Effects of hydration combined with Shenfu injection on contrast-induced acute kidney injury in acute coronary syndrome patients undergoing percutaneous coronary intervention.

  2017cites this paper
• Toward a Framework for Benefit-Risk Assessment in Diagnostic Imaging: Identifying Scenario-specific Criteria.

  2017cites this paper
• Alprostadil protects type 2 diabetes mellitus patients treated with metformin from contrast-induced nephropathy

  2017cites this paper
• Pentoxifylline and prevention of contrast-induced nephropathy: Is it efficient in patients with myocardial infarction undergoing coronary angioplasty?

  2016cites this paper
• Short‐Term High‐Dose Vitamin E to Prevent Contrast Medium–Induced Acute Kidney Injury in Patients With Chronic Kidney Disease Undergoing Elective Coronary Angiography: A Randomized Placebo‐Controlled Trial

  2016cites this paper
• Contrast-Induced Nephropathy

  2015cites this paper
• Preventive effect of reduced glutathione on contrast-induced nephropathy in elderly patients undergoing coronary angiography or intervention: a randomized, controlled trial

  2015cites this paper
• Contrast-induced nephropathy after primary angioplasty for acute myocardial infarction.

  2015cites this paper
• Oral Selenium: Can It Prevent Contrast-Induced Nephropathy Following Coronary Angiography and Angioplasty

  2015cites this paper
• EVALUATION OF PENTOXIFYLLINE IN THE PREVENTION OF CONTRAST-INDUCED NEPHROPATHY IN PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION

  2015cites this paper
• Selenium for the Prevention of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Percutaneous Interventions: A Double-Blinded Randomized Controlled Trial

  2014cites this paper
• Different interventions in preventing contrast-induced nephropathy after percutaneous coronary intervention

  2014cites this paper
• Preventive effect of pentoxifylline on contrast-induced acute kidney injury in hypercholesterolemic rats

  2014cites this paper
• Prevention of contrast-induced nephropathy with prostaglandin E1 in high-risk patients undergoing percutaneous coronary intervention

  2014cites this paper
• Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention

  2014cites this paper
• The preventive effect of pentoxifylline on contrast-induced nephropathy: a randomized clinical trial

  2013cites this paper
• OF THE 3 IAN HEART ASSOCIATION 3 EDITORIAL In the Name of God , the Most Beneficent , the Most Merciful

  2013cites this paper
• A review of the potential protective effects of pentoxifylline against drug-induced nephrotoxicity

  2013cites this paper
• Alprostadil plays a protective role in contrast-induced nephropathy in the elderly

  2013cites this paper